Todd K. Rosengart, M.D., FACS, is a professor and the DeBakey-Bard Chair of the Michael E. DeBakey Department of Surgery and Vice-President for Hospital Operations and Quality Improvement at Baylor College of Medicine. He is also a professor of heart and vascular disease at the Texas Heart Institute and a professor of molecular and cell biology at Baylor. He is the past president of the Society of Surgical Chairs and a board member of the American Association for Thoracic Surgery. Among other roles, he currently serves on the Board of Governors of the American College of Surgeons (ACS), the Baylor St. Luke’s Medical Center Board of Directors and the Leducq Foundation Trans-Atlantic Scientific Advisory Committee.
Dr. Rosengart is a National Institutes of Health-funded scientist with uninterrupted extramural funding since 1998. In 1997, he and his team at Cornell performed the world’s first viral-based cardiac gene transfer procedure, which most recently led to the successful completion of a Federal Drug Administration Fast Track Phase 1 / 2 gene therapy trial for end-stage coronary disease patients. He holds 15 issued U.S. patents, which have led to his founding multiple startup companies. Dr. Rosengart is the author of nearly 300 peer-reviewed articles and other publications with 15,000 citations, and he has mentored nearly 100 research and cardiac surgery trainees over the past 30 years.
Dr. Rosengart is the past editor of Seminars in Thoracic and Cardiovascular Surgery; the past chair of the NIH Bioengineering, Technology and Surgical Sciences Study Section; and a member of the ACS Academy of Master Surgeon Educators, amongst other organizations.
